Age distribution of 2711 patients with SA bacteraemia from June 2010—July 2012.

<p>Age distribution of 2711 patients with SA bacteraemia from June 2010—July 2012.</p

Antibiotics MIC₅₀, MIC₉₀ and breakpoints for 2 709 <i>S</i>. <i>aureus</i> isolates.

<p>Antibiotics MIC₅₀, MIC₉₀ and breakpoints for 2 709 <i>S</i>. <i>aureus</i> isolates.</p

Comparison of MRSA and MSSA in susceptibility to antimicrobial agents for 2709 <i>S</i>. <i>aureus</i> isolates.

<p>Comparison of MRSA and MSSA in susceptibility to antimicrobial agents for 2709 <i>S</i>. <i>aureus</i> isolates.</p

Antimicrobial susceptibility of 2709 SA isolates.

<p>Antimicrobial susceptibility of 2709 SA isolates.</p

Association between the most common SCC<i>mec</i> types and clindamycin susceptibility (n = 988).

<p>Association between the most common SCC<i>mec</i> types and clindamycin susceptibility (n = 988).</p

Distribution of 1003 SCC<i>mec</i> types over the period of three years per province.

<p>Distribution of 1003 SCC<i>mec</i> types over the period of three years per province.</p

Relationship between the most common SCC<i>mec</i> and <i>spa</i> types.

<p>Relationship between the most common SCC<i>mec</i> and <i>spa</i> types.</p

Distribution of the most common 393 <i>spa</i>-types per province (total number = 569).

<p>Distribution of the most common 393 <i>spa</i>-types per province (total number = 569).</p

Genotypes of 569 MRSA isolates.

<p>Genotypes of 569 MRSA isolates.</p